PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Valsartan | PF-00610355 may decrease the antihypertensive activities of Valsartan. |
| Ramipril | PF-00610355 may decrease the antihypertensive activities of Ramipril. |
| Reserpine | PF-00610355 may decrease the antihypertensive activities of Reserpine. |
| Remikiren | PF-00610355 may decrease the antihypertensive activities of Remikiren. |
| Isradipine | PF-00610355 may decrease the antihypertensive activities of Isradipine. |
| Olmesartan | PF-00610355 may decrease the antihypertensive activities of Olmesartan. |
| Nitroprusside | PF-00610355 may decrease the antihypertensive activities of Nitroprusside. |
| Diltiazem | PF-00610355 may decrease the antihypertensive activities of Diltiazem. |
| Minoxidil | PF-00610355 may decrease the antihypertensive activities of Minoxidil. |
| Treprostinil | PF-00610355 may decrease the antihypertensive activities of Treprostinil. |
| Amlodipine | PF-00610355 may decrease the antihypertensive activities of Amlodipine. |
| Nimodipine | PF-00610355 may decrease the antihypertensive activities of Nimodipine. |
| Nisoldipine | PF-00610355 may decrease the antihypertensive activities of Nisoldipine. |
| Fosinopril | PF-00610355 may decrease the antihypertensive activities of Fosinopril. |
| Trandolapril | PF-00610355 may decrease the antihypertensive activities of Trandolapril. |
| Lercanidipine | PF-00610355 may decrease the antihypertensive activities of Lercanidipine. |
| Benazepril | PF-00610355 may decrease the antihypertensive activities of Benazepril. |
| Bosentan | PF-00610355 may decrease the antihypertensive activities of Bosentan. |
| Enalapril | PF-00610355 may decrease the antihypertensive activities of Enalapril. |
| Candoxatril | PF-00610355 may decrease the antihypertensive activities of Candoxatril. |
| Mecamylamine | PF-00610355 may decrease the antihypertensive activities of Mecamylamine. |
| Losartan | PF-00610355 may decrease the antihypertensive activities of Losartan. |
| Moexipril | PF-00610355 may decrease the antihypertensive activities of Moexipril. |
| Eplerenone | PF-00610355 may decrease the antihypertensive activities of Eplerenone. |
| Lisinopril | PF-00610355 may decrease the antihypertensive activities of Lisinopril. |
| Nitroglycerin | PF-00610355 may decrease the antihypertensive activities of Nitroglycerin. |
| Metyrosine | PF-00610355 may decrease the antihypertensive activities of Metyrosine. |
| Cryptenamine | PF-00610355 may decrease the antihypertensive activities of Cryptenamine. |
| Perindopril | PF-00610355 may decrease the antihypertensive activities of Perindopril. |
| Candesartan cilexetil | PF-00610355 may decrease the antihypertensive activities of Candesartan cilexetil. |
| Fenoldopam | PF-00610355 may decrease the antihypertensive activities of Fenoldopam. |
| Tadalafil | PF-00610355 may decrease the antihypertensive activities of Tadalafil. |
| Eprosartan | PF-00610355 may decrease the antihypertensive activities of Eprosartan. |
| Quinapril | PF-00610355 may decrease the antihypertensive activities of Quinapril. |
| Telmisartan | PF-00610355 may decrease the antihypertensive activities of Telmisartan. |
| Methyldopa | PF-00610355 may decrease the antihypertensive activities of Methyldopa. |
| Irbesartan | PF-00610355 may decrease the antihypertensive activities of Irbesartan. |
| Nitrendipine | PF-00610355 may decrease the antihypertensive activities of Nitrendipine. |
| Deserpidine | PF-00610355 may decrease the antihypertensive activities of Deserpidine. |
| Pentolinium | PF-00610355 may decrease the antihypertensive activities of Pentolinium. |
| Trimethaphan | PF-00610355 may decrease the antihypertensive activities of Trimethaphan. |
| Diazoxide | PF-00610355 may decrease the antihypertensive activities of Diazoxide. |
| Captopril | PF-00610355 may decrease the antihypertensive activities of Captopril. |
| Epoprostenol | PF-00610355 may decrease the antihypertensive activities of Epoprostenol. |
| Bepridil | PF-00610355 may decrease the antihypertensive activities of Bepridil. |
| Hydralazine | PF-00610355 may decrease the antihypertensive activities of Hydralazine. |
| Cilazapril | PF-00610355 may decrease the antihypertensive activities of Cilazapril. |
| Saprisartan | PF-00610355 may decrease the antihypertensive activities of Saprisartan. |
| Spirapril | PF-00610355 may decrease the antihypertensive activities of Spirapril. |
| Mibefradil | PF-00610355 may decrease the antihypertensive activities of Mibefradil. |
| Tienilic acid | PF-00610355 may decrease the antihypertensive activities of Tienilic acid. |
| Debrisoquine | PF-00610355 may decrease the antihypertensive activities of Debrisoquine. |
| Sitaxentan | PF-00610355 may decrease the antihypertensive activities of Sitaxentan. |
| Ambrisentan | PF-00610355 may decrease the antihypertensive activities of Ambrisentan. |
| Diethylnorspermine | PF-00610355 may decrease the antihypertensive activities of Diethylnorspermine. |
| Nilvadipine | PF-00610355 may decrease the antihypertensive activities of Nilvadipine. |
| Pinacidil | PF-00610355 may decrease the antihypertensive activities of Pinacidil. |
| Temocapril | PF-00610355 may decrease the antihypertensive activities of Temocapril. |
| Riociguat | PF-00610355 may decrease the antihypertensive activities of Riociguat. |
| Macitentan | PF-00610355 may decrease the antihypertensive activities of Macitentan. |
| Hexamethonium | PF-00610355 may decrease the antihypertensive activities of Hexamethonium. |
| Aliskiren | PF-00610355 may decrease the antihypertensive activities of Aliskiren. |
| Nicorandil | PF-00610355 may decrease the antihypertensive activities of Nicorandil. |
| Efonidipine | PF-00610355 may decrease the antihypertensive activities of Efonidipine. |
| Lacidipine | PF-00610355 may decrease the antihypertensive activities of Lacidipine. |
| Manidipine | PF-00610355 may decrease the antihypertensive activities of Manidipine. |
| Rauwolfia serpentina root | PF-00610355 may decrease the antihypertensive activities of Rauwolfia serpentina root. |
| Enalaprilat | PF-00610355 may decrease the antihypertensive activities of Enalaprilat. |
| Selexipag | PF-00610355 may decrease the antihypertensive activities of Selexipag. |
| Angiotensin 1-7 | PF-00610355 may decrease the antihypertensive activities of Angiotensin 1-7. |
| Imidapril | PF-00610355 may decrease the antihypertensive activities of Imidapril. |
| BQ-123 | PF-00610355 may decrease the antihypertensive activities of BQ-123. |
| Tetrahydropalmatine | PF-00610355 may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Cicletanine | PF-00610355 may decrease the antihypertensive activities of Cicletanine. |
| Dihydralazine | PF-00610355 may decrease the antihypertensive activities of Dihydralazine. |
| Zofenopril | PF-00610355 may decrease the antihypertensive activities of Zofenopril. |
| Guanoxan | PF-00610355 may decrease the antihypertensive activities of Guanoxan. |
| Delapril | PF-00610355 may decrease the antihypertensive activities of Delapril. |
| Vincamine | PF-00610355 may decrease the antihypertensive activities of Vincamine. |
| Linsidomine | PF-00610355 may decrease the antihypertensive activities of Linsidomine. |
| Guanoxabenz | PF-00610355 may decrease the antihypertensive activities of Guanoxabenz. |
| Tolonidine | PF-00610355 may decrease the antihypertensive activities of Tolonidine. |
| Endralazine | PF-00610355 may decrease the antihypertensive activities of Endralazine. |
| Cadralazine | PF-00610355 may decrease the antihypertensive activities of Cadralazine. |
| Bietaserpine | PF-00610355 may decrease the antihypertensive activities of Bietaserpine. |
| Guanazodine | PF-00610355 may decrease the antihypertensive activities of Guanazodine. |
| Methoserpidine | PF-00610355 may decrease the antihypertensive activities of Methoserpidine. |
| Guanoclor | PF-00610355 may decrease the antihypertensive activities of Guanoclor. |
| Muzolimine | PF-00610355 may decrease the antihypertensive activities of Muzolimine. |
| Xipamide | PF-00610355 may decrease the antihypertensive activities of Xipamide. |
| Candesartan | PF-00610355 may decrease the antihypertensive activities of Candesartan. |
| Dexniguldipine | PF-00610355 may decrease the antihypertensive activities of Dexniguldipine. |
| Tocopherylquinone | PF-00610355 may decrease the antihypertensive activities of Tocopherylquinone. |
| Benazeprilat | PF-00610355 may decrease the antihypertensive activities of Benazeprilat. |
| Fosinoprilat | PF-00610355 may decrease the antihypertensive activities of Fosinoprilat. |
| Ramiprilat | PF-00610355 may decrease the antihypertensive activities of Ramiprilat. |
| Perindoprilat | PF-00610355 may decrease the antihypertensive activities of Perindoprilat. |
| Quinaprilat | PF-00610355 may decrease the antihypertensive activities of Quinaprilat. |
| Felodipine | PF-00610355 may decrease the antihypertensive activities of Felodipine. |
| Levamlodipine | PF-00610355 may decrease the antihypertensive activities of Levamlodipine. |